Skip to main content

Table 3 Frequency of LGMD2A, 2I, 2D, 2 L in European countries

From: Autosomal recessive limb-girdle muscular dystrophies in the Czech Republic

Litera-ture

Population

Number of patients analysed in the study

Number and percentage of patients with LGMD2A

Number and percentage of patients with LGMD2I

Number and percentage of patients with LGMD2D

Number and percentage of patients with LGMD2L

This study

Czech

218 LGMD2 probands

71 (67 had two mutations, 4 one); 32.6%

9; 4.1%

6; 2.8%

3; 1.4%

[28]

Italy

190 LGMD probands

59; 31.1%

14; 7.4%

16; 8.4%

4; 2.1%

[2]

Italy

155 LGMD probands

44 (30 had two mutations, 14 one); 28.4%

10; 6.4%

13; 8.4%

NI

[32]

Italy

550 patients with LGMD, myopathy, or asymptomatic hyperCKemia

102; 18.5%

16; 2.8%

37; 6.7%

NI

[33]

Italy

519 patients with LGMD, myopathy, or asymptomatic hyperCKemia

94 (76 had two mutations, 18 one); 18.1%

NI

NI

NI

[10]

Italy

530 patients with muscular dytrophy

141 (104 had two mutations and 37 one); 26.6%

NI

NI

NI

[34]

Italy

214 probands with muscular dystrophy or myopathy

NI

13 (9 had two mutations, 4 one); 6.1%

NI

NI

[35]

Germany

98 probands with LGMD2 and 102 probands with asymptomatic or minimally symptomatic hyperCKemia

NI

7; 3.5%

NI

NI

[29]

Denmark

99 LGMD2 patients

12; 12.1%

38; 38.4%

NI

NI

[4]

Dutch

67 LGMD probands

14; 20.9%

5; 7.5%

NI

NI

[30]

Dutch

68 LGMD probands

NI

NI

NI

11; 16.2%

  1. NI: no information.